Antibody-dependent enhancement of HSV-1 infection by anti-gK sera

Virus Research

Volumn 68, Issue 2, 2000, Pages 137-144

  Ghiasi, Homayon ^a,b   Perng, Guey Chuen ^a   Nesburn, Anthony B ^a,b   Wechsler, Steven L ^a,b  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADE; gK; HSV 1

Indexed keywords

ANTIBODY; HERPES SIMPLEX VACCINE; IMMUNOGLOBULIN G; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; CORNEA INJURY; FEMALE; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIGEMINUS GANGLION; VACCINATION; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS REPLICATION;

EID: 0034631737     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(00)00165-9     Document Type: Article

References (42)

1. G.A. Ananaba L.J. Anderson Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophage-like cell line J. Virol. 65 1991 5052 5060
2. A.D. Barrett E.A. Gould Antibody-mediated early death in vivo after infection with yellow fever virus J. Gen. Virol. 67 1986 2539 2542
3. P.S. Binder A review of the treatment of ocular herpes simplex infections in the neonate and immunocompromised host Cornea 3 1984 178 182
4. R.L. Burke Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use Rev. Infect. Dis. 13 1991 906 911
5. R.L. Burke Contemporary approaches to vaccination against herpes simplex virus Curr. Top. Microbiol. Immunol. 179 1992 137 158
6. C.R. Dawson Ocular herpes simplex virus infections Clin. Dermatol. 2 2 1984 56 66
7. C.R. Dawson B. Togni Herpes simplex eye infections: clinical manifestations, pathogenesis and management Surv. Ophthalmol. 21 1976 121 135
8. H. Ghiasi A.B. Nesburn R. Kaiwar S.L. Wechsler Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D Arch. Virol. 121 1991 163 178
9. H. Ghiasi R. Kaiwar A.B. Nesburn S. Slanina S.L. Wechsler Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge Virology 188 1992 469 476
10. H. Ghiasi R. Kaiwar A.B. Nesburn S.L. Wechsler Baculovirus expressed herpes simplex virus type 1 glycoprotein C protects mice from lethal HSV-1 infection Antiviral Res. 18 1992 291 302
11. H. Ghiasi R. Kaiwar A.B. Nesburn S.L. Wechsler Baculovirus-expressed glycoprotein G of herpes simplex virus type 1 partially protects vaccinated mice against lethal HSV-1 challenge Virology 190 1992 233 239
12. H. Ghiasi R. Kaiwar A.B. Nesburn S.L. Wechsler Baculovirus-expressed glycoprotein H of herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge J. Gen. Virol. 73 1992 719 722
13. H. Ghiasi R. Kaiwar A.B. Nesburn S.L. Wechsler Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological properties Virus Res. 22 1992 25 39
14. H. Ghiasi R. Kaiwar A.B. Nesburn S.L. Wechsler Expression of herpes simplex virus type 1 glycoprotein I in baculovirus: preliminary biochemical characterization and protection studies J. Virol. 66 1992 2505 2509
15. H. Ghiasi R. Kaiwar A.B. Nesburn S. Slanina S.L. Wechsler Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice J. Virol. 68 1994 2118 2126
16. H. Ghiasi R. Kaiwar S. Slanina A.B. Nesburn S.L. Wechsler Expression and characterization of baculovirus expressed herpes simplex virus type 1 glycoprotein L Arch. Virol. 138 1994 199 212
17. H. Ghiasi S. Slanina A.B. Nesburn S.L. Wechsler Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K J. Virol. 68 1994 2347 2354
18. H. Ghiasi S. Bahri A.B. Nesburn S.L. Wechsler Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins Invest. Ophthalmol. Vis. Sci. 36 1995 1352 1360
19. H. Ghiasi S.L. Wechsler R. Kaiwar A.B. Nesburn F.M. Hofman Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1 J. Virol. 69 1995 334 340
20. H. Ghiasi S. Cai A.B. Nesburn S.L. Wechsler Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection Virology 224 1996 330 333
21. H. Ghiasi S. Cai S. Slanina A.B. Nesburn S.L. Wechsler Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations Invest. Ophthalmol. Vis. Sci. 38 1997 1213 1221
22. H. Ghiasi A.B. Nesburn S. Cai S.L. Wechsler The US5 open reading frame of herpes simplex virus type 1 does encode a glycoprotein (gJ) [In Process Citation] Intervirology 41 1998 91 97
23. H. Ghiasi F.M. Hofman S. Cai G.C. Perng A.B. Nesburn S.L. Wechsler Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated mice Vaccine 17 1999 2576 2582
24. S.B. Halstead In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody J. Infect. Dis. 140 1979 527 533
25. S.B. Halstead Pathogenesis of dengue: challenges to molecular biology Science 239 1988 476 481
26. S.B. Halstead E.J. O'Rourke Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody J. Exp. Med. 146 1977 201 217
27. T. Hohdatsu M. Yamada R. Tominaga K. Makino K. Kida H. Koyama Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus J. Vet. Med. Sci. 60 1998 49 55
28. J. Homsy M. Meyer M. Tateno S. Clarkson J.A. Levy The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells Science 244 1989 1357 1360
29. S. Kanangat J. Thomas S. Gangappa J.S. Babu B.T. Rouse Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection J. Immunol. 156 1996 1110 1116
30. U. Kontny I. Kurane F.A. Ennis Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells J. Virol. 62 1988 3928 3933
31. L.R. Krilov L.J. Anderson L. Marcoux V.R. Bonagura J.F. Wedgwood Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines J. Infect. Dis. 160 1989 777 782
32. R. Littaua I. Kurane F.A. Ennis Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection J. Immunol. 144 1990 3183 3186
33. B.J. Mady D.V. Erbe I. Kurane M.W. Fanger F.A. Ennis Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors J. Immunol. 147 1991 3139 3144
34. D.J. McGeoch M.A. Dalrymple A.J. Davison A. Dolan M.C. Frame D. McNab L.J. Perry J.E. Scott P. Taylor The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1 J. Gen. Virol. 69 1988 1531 1574
35. J.K. Miller K.A. Laycock J.A. Umphress K.K. Hook P.M. Stuart J.S. Pepose A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice Cornea 15 1996 497 504
36. E.M. Opremcak B.A. Rice P.A. Wells C.S. Foster Histology and immunohistology of Igh-1-restricted herpes simplex keratitis in BALB/c congenic mice Invest. Ophthalmol. Vis. Sci. 31 1990 305 312
37. B.S. Prabhakar N. Nathanson Acute rabies death mediated by antibody Nature 290 1981 590 591
38. M.L. Raabe C.J. Issel S.J. Cook R.F. Cook B. Woodson R.C. Montelaro Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement Virology 245 1998 151 162
39. C. Sundstrom K. Nilsson Establishment and characterization of a human histiocytic lymphoma cell line (U-937) Int. J. Cancer 17 1976 565 577
40. M. Tamura R.G. Webster F.A. Ennis Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry Virology 182 1991 211 219
41. S.Z. Wang K.E. Rushlow C.J. Issel R.F. Cook S.J. Cook M.L. Raabe Y.H. Chong L. Costa R.C. Montelaro Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein Virology 199 1994 247 251
42. K.J. Yoon L.L. Wu J.J. Zimmerman H.T. Hill K.B. Platt Antibody-dependent enhancement (ADE) of porcine reproductive and respiratory syndrome virus (PRRSV) infection in pigs Viral Immunol. 9 1996 51 63